Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte C Widemann

Showing results (91-100 of 203) with videos related to

Pageof 21
Sort By:
Endocrine-Related Cancer|October 24, 2012
Bone mineral density in children and young adults with neurofibromatosis type 1Maya B Lodish, Urania Dagalakis, Ninet Sinaii, et al.
American Journal of Ophthalmology|March 5, 2013
Visual outcomes in children with neurofibromatosis type 1 and orbitotemporal plexiform neurofibromasRobert A Avery, Eva Dombi, Kelly A Hutcheson, et al.
Molecular Genetics & Genomic Medicine|September 2, 2020
Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1Heejong Sung, Paula L Hyland, Alexander Pemov, et al.
Journal of Neurosurgery|October 27, 2019
Safe marginal resection of atypical neurofibromas in neurofibromatosis type 1Charlie N Nelson, Eva Dombi, Jared S Rosenblum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology groupShana Jacobs, Elizabeth Fox, Mark Krailo, et al.
Neurology|August 17, 2016
Sleep and pulmonary outcomes for clinical trials of airway plexiform neurofibromas in NF1Scott R Plotkin, Stephanie D Davis, Kent A Robertson, et al.
Pediatric Blood & Cancer|May 23, 2014
Sirolimus for non-progressive NF1-associated plexiform neurofibromas: an NF clinical trials consortium phase II studyBrian Weiss, Brigitte C Widemann, Pamela Wolters, et al.
Pediatric Neurology|May 19, 2007
Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromasDusica Babovic-Vuksanovic, Brigitte C Widemann, Eva Dombi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2009
Randomized trial and pharmacokinetic study of pegfilgrastim versus filgrastim after dose-intensive chemotherapy in young adults and children with sarcomasElizabeth Fox, Brigitte C Widemann, Douglas S Hawkins, et al.
Blood|October 26, 2007
Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphomaElizabeth Fox, Bassem I Razzouk, Brigitte C Widemann, et al.
Pageof 21

Showing results (91-100 of 203) with videos related to

Sort By:
Pageof 21
Endocrine-Related Cancer|October 24, 2012
Bone mineral density in children and young adults with neurofibromatosis type 1Maya B Lodish, Urania Dagalakis, Ninet Sinaii, et al.
American Journal of Ophthalmology|March 5, 2013
Visual outcomes in children with neurofibromatosis type 1 and orbitotemporal plexiform neurofibromasRobert A Avery, Eva Dombi, Kelly A Hutcheson, et al.
Molecular Genetics & Genomic Medicine|September 2, 2020
Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1Heejong Sung, Paula L Hyland, Alexander Pemov, et al.
Journal of Neurosurgery|October 27, 2019
Safe marginal resection of atypical neurofibromas in neurofibromatosis type 1Charlie N Nelson, Eva Dombi, Jared S Rosenblum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology groupShana Jacobs, Elizabeth Fox, Mark Krailo, et al.
Neurology|August 17, 2016
Sleep and pulmonary outcomes for clinical trials of airway plexiform neurofibromas in NF1Scott R Plotkin, Stephanie D Davis, Kent A Robertson, et al.
Pediatric Blood & Cancer|May 23, 2014
Sirolimus for non-progressive NF1-associated plexiform neurofibromas: an NF clinical trials consortium phase II studyBrian Weiss, Brigitte C Widemann, Pamela Wolters, et al.
Pediatric Neurology|May 19, 2007
Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromasDusica Babovic-Vuksanovic, Brigitte C Widemann, Eva Dombi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2009
Randomized trial and pharmacokinetic study of pegfilgrastim versus filgrastim after dose-intensive chemotherapy in young adults and children with sarcomasElizabeth Fox, Brigitte C Widemann, Douglas S Hawkins, et al.
Blood|October 26, 2007
Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphomaElizabeth Fox, Bassem I Razzouk, Brigitte C Widemann, et al.
Pageof 21